China's capital Beijing to speed up imports of COVID drugs - official

BEIJING, Dec 19 (Reuters) - China's capital Beijing will speed up global procurement of COVID-related drugs to relieve pressure from domestic shortages, and expedite clearance for inbound shipments, a Beijing pharmaceuticals official said at a press conference on Monday.
Reporting by Beijing Newswroom; Editing by Toby Chopra
Our Standards: The Thomson Reuters Trust Principles.